Alembic Pharmaceuticals Schedules One-on-One Institutional Investor Meetings in Mumbai
Alembic Pharmaceuticals Ltd 路 Intimation 路 18 Sept 2026, 10:58 pm
Alembic Pharmaceuticals Schedules One-on-One Institutional Investor Meetings in Mumbai Alembic Pharmaceuticals Limited announced that company officials will conduct one-on-one meetings with institutional investors and analysts in Mumbai on 23rd Sep'26, starting from 10:00 AM onwards. The discussions will strictly rely on publicly available information, and no unpublished price-sensitive information (UPSI) will be shared during the interactions. Meeting schedules remain subject to change based on exigencies from either party.
Original exchange filing (PDF)
More announcements from Alembic Pharmaceuticals Ltd
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Binimetinib Tablets, 15 mg and 45 mg. 路 15 Nov 2026
- Please find attached herewith the Transcript of Post Results Conference Call held on 4th November, 2026. 路 10 Nov 2026
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC). 路 05 Nov 2026
- Please find attached Audio Recording of Investor Call. 路 05 Nov 2026
- Please find attached intimation under Regulation 30(5) of SEBI (LODR) Regulations, 2015. 路 04 Nov 2026
- Please find attached Press Release 路 04 Nov 2026
- Please find attached Investor Presentation for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
- Please find attached Press Release for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
